|
SPPL3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.03159999999647E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.380100E-04 |
| Normal-vs-Stage2 |
1.088360E-02 |
| Normal-vs-Stage3 |
3.24770000004193E-07 |
| Normal-vs-Stage4 |
1.5396799999956E-05 |
| Stage1-vs-Stage2 |
6.713400E-01 |
| Stage1-vs-Stage3 |
5.965600E-02 |
| Stage1-vs-Stage4 |
1.221840E-01 |
| Stage2-vs-Stage3 |
8.362000E-02 |
| Stage2-vs-Stage4 |
9.226100E-02 |
| Stage3-vs-Stage4 |
7.583800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.73059999994696E-06 |
| Normal-vs-AfricanAmerican |
1.846570E-01 |
| Normal-vs-Asian |
8.158300E-03 |
| Caucasian-vs-AfricanAmerican |
8.990100E-02 |
| Caucasian-vs-Asian |
9.348000E-02 |
| AfricanAmerican-vs-Asian |
4.812800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.386470E-04 |
| Normal-vs-Female |
3.59880000000423E-05 |
| Male-vs-Female |
7.249400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.000600E-04 |
| Normal-vs-Age(41-60Yrs) |
2.405800E-04 |
| Normal-vs-Age(61-80Yrs) |
1.79909999997729E-06 |
| Normal-vs-Age(81-100Yrs) |
4.595400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.122800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.360800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.036200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.642000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.178400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.611400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.90099999999905E-05 |
| Classical-VS-Follicular |
9.633000E-01 |
| Classical-VS-Other |
6.450600E-01 |
| Classical-VS-Normal |
1.769710E-04 |
| Tall-VS-Follicular |
1.721250E-03 |
| Tall-VS-Other |
1.623630E-01 |
| Tall-VS-Normal |
1.18030000217928E-08 |
| Follicular-VS-Other |
7.205800E-01 |
| Follicular-VS-Normal |
5.482800E-03 |
| Other-VS-Normal |
6.338200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.833300E-04 |
| Normal-vs-N1 |
1.72659999964075E-07 |
| N0-vs-N1 |
9.920900E-03 |
|
|
